A New Antifungal Drug Works in a Surprising Way

Arthur T Knackerbracket has processed the following story:

A newly discovered bacterial weapon against fungi can kill even drug-resistant strains, raising hopes for a new antifungal drug.

Fungal infections have been spreading rapidly and widely in recent years, fueled in part by climate change. Some fungi, including Candida auris, have developed resistance to some highly effective antifungal drugs which have been in use for decades. So scientists have been searching for new drugs to keep fungi in check.

Researchers in China may have found a new type of antifungal called mandimycin, the team reports March 19 in Nature. Mandimycin killed fungal infections in mice more effectively than amphotericin B and several other commonly used antifungal drugs. It even worked against resistant C. auris strains.

Bacteria are masters at fending off fungi, says Martin Burke, a chemist at the University of Illinois Urbana-Champaign. There's been this war raging for 2 billion years," he says. Bacteria and fungi have been building weapons to try to compete with each other for nutrients in the environment." Humans have been spying on both armies to learn how to make antibiotics and antifungal drugs.

In one such mission, Zongqiang Wang of China Pharmaceutical University in Nanjing and colleagues combed more than 300,000 bacterial genomes looking for possible weapons against fungi. One strain of Streptomyces netropsis contained a cluster of genes that encode enzymes for building the compound mandimycin.

The antifungal has a backbone structure similar to some other antifungal drugs but has two sugar molecules tacked onto its tail. Those sugars are important for how the molecule kills fungi, because they change the target that the weapon is aimed at.

[...] Instead of ergosterol, mandimycin is attracted to phospholipids, the major building blocks of membranes, Wang and colleagues discovered. It's the sugars on the tail that allow mandimycin to target phospholipids, particularly one called phosphatidylinositol, the team found. Removing those sugars caused mandimycin to latch on to ergosterol, though more weakly than existing antifungals.

While intact mandimycin proved to be a potent fungi killer, it was far less toxic to mice's kidneys and to human kidney cells grown in lab dishes than amphotericin B. Bacteria escaped mandimycin unscathed.

Read more of this story at SoylentNews.